Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Trending
Portfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Log Out
TCRR
Pre-Earnings
Is TCRR a Buy, Before Earnings?
1y ago
TCRR
Premium
Press Releases
TCR² Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
1y ago
TCRR
Premium
The Fly
Return of Adaptimmune assets complements TCR pipeline, says Guggenheim
1y ago
GSK
ADAP
Premium
Press Releases
TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1y ago
TCRR
Premium
The Fly
Alaunos Therapeutics appoints Hofmeister to board of directors
1y ago
TCRR
TCRT
Premium
The Fly
TCR2 Therapeutics downgraded to Neutral from Buy at Mizuho
1y ago
ADAP
TCRR
Premium
Press Releases
TCR² Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update
1y ago
TCRR
Premium
The Fly
TCR2 Therapeutics reports Q4 EPS ($1.56), consensus (79c)
1y ago
TCRR
Premium
The Fly
TCR2 Therapeutics downgraded to Hold from Buy at Jefferies
2y ago
ADAP
TCRR
Premium
The Fly
TCR2 Therapeutics downgraded to Hold from Buy at Truist
2y ago
ADAP
TCRR
Premium
The Fly
TCR2 Therapeutics downgraded to Hold from Buy at Truist
2y ago
TCRR
Premium
The Fly
TCR2 Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
2y ago
ADAP
TCRR
Premium
The Fly
Adaptimmune downgraded to Hold from Buy at JonesResearch
2y ago
ADAP
TCRR
Premium
Market News
Adaptimmune Craters after Acquiring TCRR
2y ago
ADAP
TCRR
Premium
Press Releases
Adaptimmune and TCR² Therapeutics Announce Strategic Combination to Create a Preeminent Cell Therapy Company for Solid Tumors
2y ago
TCRR
Premium
The Fly
Adaptimmune, TCR2 Therapeutics to combine in all-stock transaction
2y ago
ADAP
TCRR
Premium
Press Releases
TCR² Therapeutics to Present at SVB Securities Global Biopharma Conference 2023
2y ago
TCRR
Premium
Press Releases
TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2y ago
TCRR
Premium
The Fly
TCR2 Therapeutics price target raised to $10 from $8 at Piper Sandler
2y ago
TCRR
Premium
Press Releases
TCR² Therapeutics Announces Pipeline Priorities for 2023
2y ago
TCRR
Premium
The Fly
TCR2 Therapeutics announces pipeline priorities for 2023
2y ago
TCRR
Premium
The Fly
TCR2 Therapeutics initiated with a Hold at EF Hutton
2y ago
TCRR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
